Filter
5817
Filtered Results: 5817
Text search:
disease
therapy
Featured
Recommendations
545
New Publications
1468
Language
Document type
No document type
3536
Studies & Reports
834
Guidelines
794
Manuals
257
Strategic & Response Plan
129
Fact sheets
106
Training Material
70
Situation Updates
35
Infographics
21
Resource Platforms
14
Brochures
11
Online Courses
7
Dashboards/Maps
1
App
1
Videos
1
Countries / Regions
India
329
Global
206
Kenya
164
South Africa
147
Ethiopia
121
Uganda
118
Nigeria
110
Western and Central Europe
108
Nepal
107
Tanzania
95
Zambia
91
Sierra Leone
90
Malawi
90
Africa
80
Liberia
77
Rwanda
76
Latin America and the Carribbean
68
Bangladesh
62
Ghana
60
Ukraine
60
Eastern Europe
59
Myanmar / Burma
54
Russia
53
Indonesia
50
Namibia
50
Zimbabwe
47
Philippines
45
Asia
44
Lesotho
40
Congo, Democratic Republic of
35
Syria
35
Cambodia
33
Germany
31
South–East Asia Region
29
Mozambique
28
Senegal
27
Haiti
25
Brazil
25
South Sudan
24
Botswana
24
East and Southern Africa
23
West and Central Africa
23
Eswatini/ Swaziland
21
Middle East and North Africa
18
Cameroon
17
Burkina Faso
16
Guinea
15
Pakistan
13
Colombia
13
Yemen
13
Eastern Europe and Central Asia
13
Paraguay
13
Albania
13
Tajikistan
12
USA
11
Venezuela
11
Afghanistan
10
Sudan
9
Peru
9
Angola
9
Iraq
8
Benin
8
Madagascar
8
Western Pacific Region
8
Somalia
7
Thailand
7
Argentina
7
Bolivia
7
Armenia
7
Southern Africa
7
Moldova
7
Georgia
7
Vietnam
7
Central African Republic
6
North Macedonia
6
Ecuador
6
Jordan
5
Lebanon
5
China
5
Sri Lanka
5
Bhutan
5
Iran
5
Kyrgyzstan
5
North America
5
Spain
5
Mali
4
Guinea-Bissau
4
Saudi Arabia
4
Chile
4
Poland
4
Laos
4
United Kingdom
4
Turkey
3
Egypt
3
Chad
3
Papua New Guinea
3
Hungary
3
Canada
3
Timor Leste/ East Timor
3
Romania
3
Kazakhstan
3
Jamaica
3
Switzerland
2
Serbia
2
Libya
2
Other region
2
Fiji
2
Qatar
2
Bulgaria
2
Estonia
2
Slovakia
2
Uzbekistan
2
Gabon
2
France
2
Mauritius
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Togo
1
Gambia
1
Malaysia
1
Ireland
1
Singapore
1
Austria
1
Burundi
1
Greece
1
Mexico
1
Palestine
1
North Korea
1
Djibouti
1
Mongolia
1
Lithuania
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2190
Clinical Guidelines
603
Public Health
334
Women & Child Health
248
Key Resources
121
Capacity Building
85
Pharmacy & Technologies
60
Annual Report MEDBOX
2
General Guidelines
1
Toolboxes
HIV
703
TB
507
Mental Health
495
COVID-19
342
AMR
242
NTDs
182
NCDs
178
Caregiver
149
Pharmacy
144
Disability
143
Ebola
111
Rapid Response
107
Conflict
88
Refugee
69
Planetary Health
54
Global Health Education
45
Natural Hazards
36
Cholera
33
Health Financing Toolbox
29
Polio
26
Specific Hazards
22
Zika
18
Social Ethics
12
South Sudan
1
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, ...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable ... (NCDs) worldwide. There is currently
an epidemiological transition on the continent, where NCDs is projected
to outpace communicable diseases within the current decade. Unchecked
increases in CVD risk factors have contributed to the growing burden of three
major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age
standardized disability-adjusted life years (DALYs) due to hypertensive heart
disease (HHD) were recorded in Africa. The contributory causes of heart failure
are changing—whilst HHD and cardiomyopathies still dominate, ischemic
heart disease is rapidly becoming a significant contributor, whilst rheumatic
heart disease (RHD) has shown a gradual decline. In a continent where health
systems are traditionally geared toward addressing communicable diseases,
several gaps exist to adequately meet the growing demand imposed by CVDs.
Among these, high-quality research to inform interventions, underfunded
health systems with high out-of-pocket costs, limited accessibility and
affordability of essential medicines, CVD preventive services, and skill
shortages. Overall, the African continent progress toward a third reduction
in premature mortality come 2030 is lagging behind. More can be done in
the arena of effective policy implementation for risk factor reduction and
CVD prevention, increasing health financing and focusing on strengthening
primary health care services for prevention and treatment of CVDs, whilst
ensuring availability and affordability of quality medicines. Further, investing
in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on
interventions. This review summarizes the current CVD burden, important
gaps in cardiovascular medicine in Africa, and further highlights priority
areas where efforts could be intensified in the next decade with potential
to improve the current rate of progress toward achieving a 33% reduction
in CVD mortality.
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional .... Despite prior perception of low NCDs mortality rates, current evidence suggests that SSA is now at the dawn of the epidemiological transition with contemporary double burden of disease from NCDs and communicable diseases. In SSA, cardiovascular diseases (CVDs) are the most frequent causes of NCDs deaths, responsible for approximately 13% of all deaths and 37% of all NCDs deaths. Although ischemic heart disease (IHD) has been identified as the leading cause of CVDs mortality in SSA followed by stroke and hypertensive heart disease from statistical models, real field data suggest IHD rates are still relatively low. The neglected endemic CVDs of SSA such as endomyocardial fibrosis and rheumatic heart disease as well as congenital heart diseases remain unconquered. While the underlying aetiology of heart failure among adults in high-income countries (HIC) is IHD, in SSA the leading causes are hypertensive heart disease, cardiomyopathy, rheumatic heart disease, and congenital heart diseases. Of concern is the tendency of CVDs to occur at younger ages in SSA populations, approximately two decades earlier compared to HIC. Obstacles hampering primary and secondary prevention of CVDs in SSA include insufficient health care systems and infrastructure, scarcity of cardiac professionals, skewed budget allocation and disproportionate prioritization away from NCDs, high cost of cardiac treatments and interventions coupled with rarity of health insurance systems. This review gives an overview of the descriptive epidemiology of CVDs in SSA, while contrasting with the HIC and highlighting impediments to their management and making recommendations.
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases<...
This is an update (third edition) of the BACPR Standards & Core Components and represents current evidence-based best practice and a pragmatic overview of the structure and function of Cardiovascular Prevention and Rehabilitation Programmes (CPRPs) in the UK. The previously described seven standards...
In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South
American Society of Cardiology, aimed to formulate strategies, measures, and actions for cardiovascular disease prevention
and ...
Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden ...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory ...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory ...
The article outlines the prioritized research agenda for the prevention and control of chronic respiratory diseases (CRDs) as part of the World Health Organization's (WHO) action plan on noncommunicable di... (NCDs) from 2008 to 2013. It highlights the significant global impact of CRDs, including asthma, chronic obstructive pulmonary disease (COPD), and other related conditions, particularly in low- and middle-income countries (LMICs). The document stresses the need for effective prevention strategies and better surveillance, as well as enhanced healthcare infrastructure and resources in LMICs. It calls for research into CRD risk factors, effective interventions, and integrated care approaches that align with broader NCD prevention programs. The article emphasizes the importance of public health initiatives and cross-sector collaborations to reduce the disease burden and improve patient outcomes.
Accessed 10 April 2015
Mem Inst Oswaldo Cruz , Rio de Janeiro, Vol. 110 (3): 377-386, May 2015
Infectious disease outbreaks are periods of
great uncertainty. Events unfold, resources
and capacities that are often limited
are stretched yet further, and decisions
for a public health response must be
made quickly, even though the evide...
Published OnlineJuly 14, 2021https://doi.org/10.1016/S2214-109X(21)00164-9. New Lancet research offers the first comprehensive analysis of the growing footprint of noncommunicable and injury-related neurological disorders to India’s overall disease...
In one of his final essays, statesman and former United Nations secretary general Kofi Annan said, ‘Snakebite is the most important tropical disease you’ve never heard of’. Mr. Annan firmly believed that victims of snakebite envenoming should ...
This guide for patients aims to provide you with an overview of the latest evidence-based recommendations for the prevention of cardiovascular disease. In particular, it should help you to understand:
• how cardiovascular ... risk is assessed
• the importance of lifestyle modifications for prevention of cardiovascular disease
• treatments and treatment goals that may be considered appropriate based on
your risk profile
